These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37927610)

  • 1. Differential drug response in pulmonary arterial hypertension: The potential for precision medicine.
    Miller E; Sampson CU; Desai AA; Karnes JH
    Pulm Circ; 2023 Oct; 13(4):e12304. PubMed ID: 37927610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnicity in Pulmonary Arterial Hypertension: Possibilities for Novel Phenotypes in the Age of Personalized Medicine.
    Medrek SK; Sahay S
    Chest; 2018 Feb; 153(2):310-320. PubMed ID: 28887060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?
    Jacobs A; Preston IR; Gomberg-Maitland M
    Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial hypertension: pathogenesis and clinical management.
    Thenappan T; Ormiston ML; Ryan JJ; Archer SL
    BMJ; 2018 Mar; 360():j5492. PubMed ID: 29540357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension.
    Yamamura A
    J Smooth Muscle Res; 2014; 50():8-17. PubMed ID: 24770445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    Ruopp NF; Cockrill BA
    JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
    Zeng C; Liu J; Zheng X; Hu X; He Y
    Respir Res; 2023 Nov; 24(1):263. PubMed ID: 37915044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of pulmonary arterial hypertension].
    Montani D; Sitbon O; Jaïs X; Cabrol S; Simonneau G; Humbert M
    Presse Med; 2005 Nov; 34(19 Pt 2):1445-55. PubMed ID: 16301976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
    Ivy DD; McMurtry IF; Colvin K; Imamura M; Oka M; Lee DS; Gebb S; Jones PL
    Circulation; 2005 Jun; 111(22):2988-96. PubMed ID: 15927975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives.
    Coons JC; Empey PE
    Pharmgenomics Pers Med; 2023; 16():729-737. PubMed ID: 37457231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive model of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension.
    Yorifuji K; Uemura Y; Horibata S; Tsuji G; Suzuki Y; Nakayama K; Hatae T; Kumagai S; Emoto N
    Can J Physiol Pharmacol; 2020 Sep; 98(9):625-628. PubMed ID: 32433892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor antagonists for pulmonary arterial hypertension.
    Liu C; Chen J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004434. PubMed ID: 16856046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatments for pulmonary arterial hypertension].
    Montani D; Jaïs X; Ioos V; Sitbon O; Simonneau G; Humbert M
    Rev Med Interne; 2004 Oct; 25(10):720-31. PubMed ID: 15471598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension.
    Alencar AKN; Montes GC; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Front Pharmacol; 2017; 8():858. PubMed ID: 29255415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of pulmonary arterial hypertension in 2014].
    Aschermann M; Jansa P
    Vnitr Lek; 2014 Apr; 60(4):282-8. PubMed ID: 24985985
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.